Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H28N2O |
Molecular Weight | 336.4705 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=PJMPHNIQZUBGLI-UHFFFAOYSA-N
InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3
Molecular Formula | C22H28N2O |
Molecular Weight | 336.4705 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:45:50 UTC 2023
by
admin
on
Sat Dec 16 17:45:50 UTC 2023
|
Record UNII |
UF599785JZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN01AH51
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
NDF-RT |
N0000175684
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
LIVERTOX |
NBK548026
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
CFR |
21 CFR 524.916
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-VATC |
QN02AB03
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-ATC |
N01AH01
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-VATC |
QN02AB53
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
NDF-RT |
N0000175690
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-ATC |
N01AH51
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-ATC |
N02AB03
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-VATC |
QN02AB73
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
WHO-VATC |
QN01AH01
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EFFENTORA (AUTHORIZED: PAIN)
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
DEA NO. |
9801
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PECFENT (AUTHORIZED: PAIN)
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3345
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
119915
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
CHEMBL596
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
DTXSID9023049
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
4337
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | RxNorm | ||
|
UF599785JZ
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
D005283
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
3329
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
UF599785JZ
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
SUB07597MIG
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
100000090377
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
Fentanyl
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
SS-102
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
1626
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
207-113-6
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
DB00813
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
1608
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
437-38-7
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
RECUVYRA [AUTHORIZED]
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | DOGS | ||
|
m5298
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | Merck Index | ||
|
1164
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
1269902
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
C494
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY | |||
|
FENTANYL
Created by
admin on Sat Dec 16 17:45:54 UTC 2023 , Edited by admin on Sat Dec 16 17:45:54 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
DERIVATIVE -> PARENT |
|
||
|
CUMULATIVE EXCRETION |
URINE
|
||
|
PRECURSOR->PARENT |
|
||
|
TARGET -> AGONIST |
HUMAN RECEPTOR
AGONIST
Ki
|
||
|
PRECURSOR->PARENT |
|
||
|
PRECURSOR->PARENT |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Possible deadly drug interaction with CYP3A4 inhibitors
MAJOR
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
OFF TARGET->NON-INHIBITOR |
|
||
|
TARGET -> AGONIST |
AGONIST
EC50
|
||
|
OFF TARGET->NON-INHIBITOR |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
PARENT -> DERIVATIVE |
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
CUMULATIVE EXCRETION |
FECAL
|
||
|
EXCRETED UNCHANGED |
FECAL; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Relative Response Factor - 1.0
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
ED50(mg/kg) = 0.0061, LD50(mg/kg) = 62, Potency ratio to morphine = 54.1, Potency ratio to fentanyl = 1
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||